The Relevance of Clinical Trials and Real-World Data

The International Eczema Council will hold the Relevance of Clinical Trials and Real-World Data Symposium on October 3 2026.

Founded in 2014 by Drs. Amy Paller and Emma Guttman, the International Eczema Council (IEC) is a global non-profit organisation led by dermatology and allergy experts on atopic dermatitis. The IEC is dedicated to improving patient care by promoting research, education, and best practices in treatment for atopic dermatitis in people worldwide.

This session will examine how clinical trials and real-world evidence are shaping current and future care in atopic dermatitis. Faculty will review practical lessons from trial setup and late-phase study design, address challenges in paediatric research, and discuss how emerging data on biomarkers, disease heterogeneity, treatment patterns, safety, and regulatory-grade evidence can help bridge mechanistic insights with clinical decision-making.

At the end of the session, participants will be able to:
1. Describe key operational and design considerations involved in setting up and conducting late-phase clinical trials in atopic dermatitis.
2. Compare the strengths and limitations of clinical trial data and real-world evidence when evaluating treatment effectiveness and safety, including in paediatric populations.
3. Identify how biomarkers, phenotype-endotype correlations, and high-quality registry or real-world datasets may support patient stratification and treatment decision-making in atopic dermatitis.

Where: Austria Center Vienna, Bruno-Kreisky-Platz 1, 1220, Vienna, Austria.
When: 3 October 2026.